PPARA and metabolic dysfunction-associated steatohepatitis: Decreased PPARα in NASH also enhanced the DNA-binding capacity of c-Jun N-terminal kinase 1 (JNK1) and nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) leading to increased hepatic inflammation [87].